Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
C-suite
Biotech
Boundless drops clinical-stage cancer drug, shakes up C-suite
Boundless Bio's freshman year on the public markets hasn’t been easy, with layoffs in the summer followed by dropping a clinical-stage candidate
James Waldron
Dec 13, 2024 7:30am
Gilead's O'Day relishes reunion as Berger agrees to leave Sanofi
Dec 13, 2024 5:20am
Longtime BioMarin CEO hands off baton—Chutes & Ladders
Nov 3, 2023 9:30am
Orthofix board gives CEO, other C-suite members the boot
Sep 12, 2023 2:56pm
Zimmer Biomet promotes a flurry of execs after CEO switch-up
Sep 7, 2023 12:05pm
Mesoblast CEO takes 30% pay cut to fund 3rd shot at FDA approval
Aug 31, 2023 5:42am
